Identification and characterization of imidazoline-binding sites from calf striatum

By Czerwiec E.   De Backer J.-P.   Flamez A.   Vauquelin G.  

European Journal of Pharmacology, Vol. 315, Iss. 1, 1996-11 ,pp. : 99-109

Elsevier

Access to resources Recommend Favorite

Characterisation of new efaroxan derivatives for use in purification of imidazoline-binding sites

By Chan S.L.F.   Pallett A.L.   Clews J.   Ramsden C.A.   Chapman J.C.   Kane C.   Dunne M.J.   Morgan N.G.  

European Journal of Pharmacology, Vol. 355, Iss. 1, 1998-08 ,pp. : 67-76

Elsevier

Access to resources Recommend Favorite

Imidazoline Binding Sites and Receptors in Cardiovascular Tissue - an investigation into their relationship to imidazoline, 2 and H 3 receptors

By Molderings G.J.   Gothert M.  

General Pharmacology, Vol. 32, Iss. 1, 1999-01 ,pp. : 17-22

Elsevier

Access to resources Recommend Favorite

Heightened aggression after chronic flunitrazepam in male rats: potential links to cortical and caudate–putamen-binding sites

By Almeida Rosa   Benini Quelin   Betat Juliana   Hipólide Débora   Miczek Klaus   Svensson Anders  

Psychopharmacology, Vol. 197, Iss. 2, 2008-04 ,pp. : 309-318

Springer Publishing Company

Access to resources Recommend Favorite

Clotrimazole and efaroxan inhibit red cell Gardos channel independently of imidazoline I 1 and I 2 binding sites

By Coupry I.   Armsby C.C.   Alper S.L.   Brugnara C.   Parini A.  

European Journal of Pharmacology, Vol. 295, Iss. 1, 1996-01 ,pp. : 109-112

Elsevier

Access to resources Recommend Favorite